Why is Valiant Laborato falling/rising?

As of 30-Jun, Valiant Laboratories Ltd is experiencing a decline in its stock price, currently at Rs 113.60, which reflects a decrease of Rs 1.75 or 1.52%. Today's price summary indicates that the stock has underperformed its sector by 2.21%, touching an intraday low of Rs 112.7. Despite trading above its moving averages for 5, 20, 50, 100, and 200 days, the stock has seen a significant drop in investor participation, with delivery volume falling by 49.41% compared to the 5-day average. Over the past year, the stock has generated a return of -18.48%, significantly underperforming the benchmark, which has risen by 5.79% during the same period. While there were positive results in the latest quarter, including a higher PAT and net sales, the long-term fundamentals remain weak, with a negative EBITDA and poor growth metrics.
In the broader market context, Valiant Laboratories' short-term performance over the past week shows a gain of 1.66%, which is lower than the Sensex's increase of 2.09%. This underperformance is indicative of the stock's struggles, particularly given its consistent negative returns over the past year and three years. The recent increase in institutional investor participation, which rose by 0.64%, may provide some support; however, the overall sentiment remains cautious due to the company's weak long-term growth prospects and ability to service its debt. The combination of these factors contributes to the stock's current downward trajectory.